# Pulmonary Function Among COVID-19 Patients in Home Isolation Program

**Authors:** Narongkorn Saiphoklang, Pitchayapa Ruchiwit, Apichart Kanitsap, Pichaya Tantiyavarong, Pasitpon Vatcharavongvan, Srimuang Palungrit, Kanyada Leelasittikul, Apiwat Pugongchai, Orapan Poachanukoon

PMC · DOI: 10.3390/medsci13030088 · 2025-07-09

## TL;DR

This study found that nearly a third of mild COVID-19 patients had abnormal lung function, even after recovery, suggesting possible long-term effects.

## Contribution

The study is the first to investigate pulmonary function in mild or asymptomatic COVID-19 patients under home isolation.

## Key findings

- Abnormal lung function was observed in 28.4% of mild or asymptomatic COVID-19 patients.
- Restrictive lung patterns and small airway disease were the most common abnormalities.
- Higher body mass index was associated with a lower risk of abnormal lung function.

## Abstract

Background: Patients with mild coronavirus disease 2019 (COVID-19) are usually managed in an outpatient setting. Pulmonary functions in this setting have not been explored. This study aimed to determine abnormal lung functions in COVID-19 patients under a home isolation program. Methods: A prospective study was conducted in asymptomatic or mild COVID-19 patients with normal chest radiographs at two medical centers in Thailand. Spirometry data, including forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF), forced expiratory flow at 25–75% of FVC (FEF25–75), and bronchodilator responsiveness (BDR), were collected. Spirometry was performed after disease resolution at baseline and 3-month follow-up. Abnormal lung functions were classified into airway obstruction, restrictive defect, mixed defect, small airway disease, and BDR. Results: A total of 250 patients (58% female) were included. The mean age was 37.4 ± 15.2 years. Asymptomatic patients accounted for 7.6%. Common symptoms included fever (55.6%) and cough (60.0%). Abnormal lung functions were observed in 28.4% of patients, with a restrictive lung pattern (14.4%), airway obstruction (4.8%), mixed defect (0.4%), small airway disease (8.4%), and BDR (2.8%). Significant changes from baseline were noted in FVC (1.21%), FEV1/FVC (−1.51%predicted), PEF (0.06%), and FEF25–75 (−2.76%). Logistic regression analysis indicated that a higher body mass index was associated with a lower risk of abnormal lung function. Conclusions: Ventilatory defects were observed in one-third of patients with mild COVID-19 who did not require hospitalization, mainly presenting as restrictive patterns and small airway disease. Even mild cases may have residual pulmonary impairment, warranting further long-term studies.

## Linked entities

- **Diseases:** coronavirus disease 2019 (MONDO:0100096)

## Full-text entities

- **Diseases:** fever (MESH:D005334), small airway disease (MESH:D056151), Ventilatory defects (MESH:D012131), airway obstruction (MESH:D000402), cough (MESH:D003371), COVID-19 (MESH:D000086382), Abnormal lung functions (MESH:D008171), restrictive defect (MESH:D002313)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12286095/full.md

---
Source: https://tomesphere.com/paper/PMC12286095